Desmond Yip

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

D. Tu, M. Moore, J. Zalcberg, 2015, European journal of cancer.

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

C. Underhill, S. Brule, C. O'Callaghan, 2015, European journal of cancer.

Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site

P. Harper, C. Karapetis, K. Ryder, 2001, Medical oncology.

Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single‐centre experience with long‐term follow up *

C. Steer, C. Karapetis, D. Yip, 2003, Internal medicine journal.